🔍

Reliance Chemotex Industries Limited (RELCHEMQ)

₹112.87 +1.48% last close, 16 Oct

📊 NSE: RELCHEMQ 🏢 Textiles - Spinning - Synthetic / Blended 📢 Latest filing: 09 Oct 2026 📝 Analysis written: 14 Dec 2025

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Reliance Chemotex's revenue was ₹98.8 Cr (+7.0% year on year, +12.1% on the previous quarter), and net profit ₹1.4 Cr (+28.9% year on year); the operating margin was 10.9%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹98.8	+7.0%	+12.1%
Operating profit	₹10.8	+0.4%	+20.4%
Net profit	₹1.4	+28.9%	-21.9%
EPS (₹)	1.81	+28.4%	-22.0%
Operating margin	10.9%	—	—

Full quarterly financials → Results calendar →

RELCHEMQ delivery percentage

NSE end-of-day data for Fri, 16 Oct 2026

On Fri, 16 Oct 2026, 62.53% of the RELCHEMQ shares traded on NSE were taken to delivery, against the stock's own 20-session average of 61.45%. That is close to its usual level. Turnover was only ₹1 lakh, so a handful of trades can move this figure. Volume was 0.1 times its average, well below normal.

62.53%Delivery, 16 Oct

61.45%Own 20-session average

0.1×Volume vs its average

₹112.87NSE close · +1.48%

Delivery in the last 5 sessions: 60.5% · 54.6% · 67.0% · 67.0% · 62.5%

Delivery across the market →

A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed

📢 Recent Corporate Announcements

Reliance Chemotex Submits Demat Compliance Certificate for Q2 FY27

🟡 NEUTRAL ⭐ 1/10

ROUTINE 📅 09 Oct 2026, 12:35 PM

Reliance Chemotex Industries Limited has submitted its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The certificate was issued by Bigshare Services Pvt. Ltd., the company's Registrar and Share Transfer Agent, on October 08, 2026. It confirms that security certificates received for dematerialization were processed, mutilated, and cancelled within the prescribed 15-day period. This is a standard quarterly administrative filing with no financial impact.

Quarter ended September 30, 2026 compliance certificate submitted under Regulation 74(5)
RTA confirmation issued by Bigshare Services Pvt. Ltd. on October 08, 2026
Security certificates verified, mutilated, and cancelled within 15 days of receipt

💡 No action is required as this is a recurring regulatory compliance filing. Investors should look out for upcoming quarterly financial results for fundamental updates.

Reliance Chemotex Re-Appoints Sanjiv Shroff as MD for 3 Years; Approves AGM Resolutions

🟡 NEUTRAL ⭐ 3/10

MANAGEMENT 📅 24 Sep 2026, 04:30 PM

Reliance Chemotex Industries announced shareholder approval at its 48th AGM for the re-appointment of Mr. Sanjiv Shroff as Managing Director for a 3-year term from September 1, 2026 to August 31, 2029. Mr. Shroff has served as MD since 1988, ensuring leadership continuity for the micro-cap textile company (market cap ₹90 Cr, FY26 revenue ₹362 Cr). Shareholders also approved the re-appointments of Executive Director Mr. Ameya Shroff and Non-Executive Director Mr. Vijay Kumar Nagar, both retiring by rotation.

Re-appointment of Mr. Sanjiv Shroff as MD for 3 years effective September 01, 2026 to August 31, 2029
Shareholders approved all resolutions at the 48th AGM held on September 24, 2026
Mr. Ameya Shroff re-appointed as Executive Director (Whole-time Director) liable to retire by rotation
Mr. Vijay Kumar Nagar re-appointed as Non-Executive & Non-Independent Director liable to retire by rotation

💡 Track the upcoming Q2 FY27 financial results and margin trajectory, particularly raw material cost trends and high debt leverage (D/E of 1.87x).

Reliance Chemotex Shareholders Approve ₹0.50 Dividend and MD Re-Appointment at 48th AGM

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 24 Sep 2026, 04:22 PM

Reliance Chemotex Industries announced the voting results and Scrutinizer's Report for its 48th Annual General Meeting held on September 24, 2026. Shareholders approved all agenda items with over 99.99% majority, including the adoption of FY26 financial statements and declaration of a final dividend of ₹0.50 per share (5% on ₹10 face value). In addition, shareholders approved the re-appointment of Managing Director Mr. Sanjiv Shroff for a 3-year term, ensuring leadership continuity.

Declared final dividend of ₹0.50 per equity share of face value ₹10 for FY26
All 6 resolutions passed with 99.99% of votes cast in favour
Re-appointment of Mr. Sanjiv Shroff as Managing Director approved for a 3-year term
Total of 5,090,841 valid votes cast across remote e-voting and AGM voting

💡 Track the dividend payout timeline and upcoming Q2 FY27 financial results to monitor operating margin trends and raw material cost pressures.

Reliance Chemotex Sets Sept 18 Record Date for Rs 0.50/Share Dividend; AGM on Sept 24

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 31 Aug 2026, 04:55 PM

Reliance Chemotex Industries Limited has issued the notice for its 48th Annual General Meeting (AGM) scheduled for September 24, 2026, alongside submitting its FY26 Annual Report. The Board had recommended a final dividend of Rs 0.50 per equity share (5% on face value of Rs 10), subject to shareholder approval. The record date for dividend entitlement and e-voting eligibility has been fixed as Friday, September 18, 2026. Operational data from the annual report shows the company operated 68,256 spindles and produced 19,074 tonnes of yarn in FY26, with exports generating 34.54% of total revenues.

Final dividend of Rs 0.50 per equity share (5% on face value of Rs 10) recommended for FY26.
Record date and cut-off date for dividend and remote e-voting fixed as September 18, 2026.
48th AGM to be held virtually on September 24, 2026; remote e-voting active September 21–23, 2026.
FY26 operating metrics show 68,256 active spindles, 19,074 tonnes production, and 34.54% export revenue share.

💡 Eligible shareholders seeking the Rs 0.50/share dividend must ensure share ownership before the September 18, 2026 record date, with remote e-voting open from September 21 to September 23, 2026.

Reliance Chemotex Re-appoints Sanjiv Shroff as MD for 3-Year Term

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 11 Aug 2026, 01:18 PM

Reliance Chemotex Industries has approved the re-appointment of Mr. Sanjiv Shroff as Managing Director for a three-year term, effective September 1, 2026, to August 31, 2029. Mr. Shroff has led the company as MD since 1988, providing long-term leadership continuity for the Rs 95 Cr market cap firm. The appointment is subject to shareholder approval and maintains the current family-led management structure, with his two sons also serving as Whole-time Directors. This stability is critical as the company manages a high debt-to-equity ratio of 1.87 and integrates a recent 25% capacity expansion.

Re-appointment for a 3-year term starting September 1, 2026
Mr. Sanjiv Shroff has served as Managing Director for 38 years since 1988
Leadership oversees a TTM revenue base of Rs 362 Cr and debt of Rs 268 Cr
Promoter holding remains stable at 67.69% as of March 2026
Management includes two sons, Mr. Rahul Shroff and Mr. Ameya Shroff, as Executive Directors

💡 Investors should monitor the upcoming shareholder vote for approval and track the management's ability to improve the interest coverage ratio (currently 1.81x) following their recent capacity expansion.

Sept 18 Set as Record Date for Dividend and 48th AGM

🟡 NEUTRAL ⭐ 4/10

DIVIDEND 📅 11 Aug 2026, 01:00 PM

Reliance Chemotex Industries Limited has fixed September 18, 2026, as the record date for determining shareholder eligibility for the FY26 dividend and participation in the 48th Annual General Meeting (AGM). The company, which operates in the synthetic spinning industry, reported a TTM PAT of ₹5 Cr on a revenue of ₹362 Cr. The register of members will remain closed from September 18 to September 24, 2026. Remote e-voting for the AGM is scheduled between September 21 and September 23, 2026.

Record date for FY26 dividend and 48th AGM fixed for September 18, 2026.
Book closure period scheduled from September 18, 2026, to September 24, 2026 (7 days).
Remote e-voting window opens at 09:00 AM on September 21 and closes at 5:00 PM on September 23, 2026.
The company reported a TTM EPS of ₹6.98 against a current market price of ₹128.0.

💡 Investors should verify the dividend amount in the full AGM notice and ensure shares are in their demat account by the record date to be eligible for the payout.

Reliance Chemotex Q1 FY27: Net Profit up 29% YoY to ₹1.37 Cr; Revenue grows 7% to ₹98.8 Cr

🟢 POSITIVE ⭐ 6/10

EARNINGS 📅 11 Aug 2026, 12:51 PM

Reliance Chemotex reported a 7% YoY increase in revenue to ₹98.82 Cr for the quarter ended June 30, 2026. Net profit grew 29% YoY to ₹1.37 Cr, although it saw a sequential decline of 22% from the ₹1.75 Cr reported in Q4 FY26. Finance costs remain a significant burden at ₹6.76 Cr, accounting for nearly 7% of total revenue, which is consistent with the company's high debt-to-equity ratio of 1.87. The company continues to focus on its single business segment, Yarns, amid volatile raw material costs.

Revenue from operations grew 7% YoY to ₹98.82 Cr from ₹92.36 Cr in the year-ago period.
Net profit increased 29% YoY to ₹1.37 Cr, up from ₹1.06 Cr in June 2025.
Finance costs rose to ₹6.76 Cr, representing a significant portion of the ₹9.97 Cr total income.
Raw material costs increased to ₹54.13 Cr, up 16.8% from ₹46.35 Cr in the same quarter last year.
Basic and Diluted EPS for the quarter stood at ₹1.81, compared to ₹1.41 YoY.

💡 Investors should monitor the company's ability to manage its high debt levels (₹268 Cr) and interest coverage, as finance costs consume a large portion of operating profits. Watch for the impact of the 25% capacity expansion on future revenue growth and margin improvement in upcoming quarters.

29% YoY PAT Growth in Q1 FY27; Revenue Up 7% to ₹98.82 Cr

🟡 NEUTRAL ⭐ 6/10

EARNINGS 📅 11 Aug 2026, 12:43 PM

Reliance Chemotex reported a 7% YoY increase in revenue to ₹98.82 Cr for the quarter ended June 30, 2026. Net profit grew 28.5% YoY to ₹1.37 Cr, although it saw a sequential decline of 21.7% compared to the March 2026 quarter. Profitability remains constrained by high finance costs of ₹6.76 Cr, which consumed nearly 7% of total revenue. The company's high leverage (D/E of 1.87) continues to be a significant factor in its financial performance.

Revenue from operations increased 7% YoY to ₹98.82 Cr from ₹92.36 Cr.
Net profit rose to ₹1.37 Cr, a 28.5% increase over the ₹1.06 Cr reported in Q1 FY26.
Finance costs remained elevated at ₹6.76 Cr, representing a 4.1% increase YoY.
Raw material costs rose to ₹54.13 Cr, accounting for 54.8% of total revenue.
Earnings Per Share (EPS) for the quarter stood at ₹1.81, up from ₹1.41 YoY.

💡 Investors should monitor the utilization levels of the recently added 13,440 spindles and the company's ability to improve interest coverage, which was previously reported at a low 1.81x.

Reliance Chemotex Submits Quarterly Share Dematerialization Certificate for June 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 10 Jul 2026, 06:15 PM

Reliance Chemotex Industries Limited has filed its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The document confirms that share certificates received for dematerialization during the quarter ended June 30, 2026, were processed, mutilated, and cancelled by the Registrar and Share Transfer Agent (RTA). The RTA, Bigshare Services Pvt. Ltd., confirmed that the names of the depositories were substituted in the register of members within the mandated 15-day period. This is a standard administrative filing with no impact on the company's financial health or operations.

Compliance certificate issued for the quarter ended June 30, 2026
Dematerialization requests processed and confirmed within 15 days of receipt
Confirmation provided by Registrar and Share Transfer Agent, Bigshare Services Pvt. Ltd.
Verification and cancellation of physical certificates completed as per SEBI norms

💡 No action is required as this is a routine regulatory filing. Investors should monitor upcoming quarterly financial results for updates on the company's 25% capacity expansion and diversification into technical textiles.

Reliance Chemotex Promoters Confirm No New Share Encumbrances for FY 2025-26

🟡 NEUTRAL ⭐ 3/10

REGULATORY 📅 29 Jun 2026, 07:08 PM

Sanjiv Shroff, representing the promoter group of Reliance Chemotex Industries Limited, has submitted a declaration under SEBI (SAST) Regulation 31(4). The filing confirms that no new encumbrances or pledges were created on the promoter group's shares during the financial year ended March 31, 2026, beyond what was already disclosed. The promoter group maintains a significant 67.69% stake in the company, which is a specialized synthetic yarn manufacturer with a TTM revenue of Rs 362 Cr.

Declaration covers the entire financial year ended March 31, 2026
Promoter group holding remains stable at 67.69% as of the latest quarterly data
A total of 13 entities and individuals are identified as part of the Promoter Group and PAC
Confirmation provided that no direct or indirect encumbrances were made during the period

💡 This is a routine annual compliance filing. Investors should focus on the company's high Debt-to-Equity ratio of 1.87 and the progress of its 25% capacity expansion (13,440 spindles) mentioned in financial reports.

Reliance Chemotex Trading Window to Close from July 1, 2026 for Q1 Results

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 22 Jun 2026, 01:23 PM

Reliance Chemotex Industries Limited has announced the closure of its trading window starting July 1, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations. This closure is ahead of the declaration of the company's un-audited financial results for the quarter ending June 30, 2026. The restriction applies to directors, promoters, and designated persons, preventing them from dealing in company securities. The window will reopen 48 hours after the financial results are officially announced to the exchanges.

Trading window closure begins on July 1, 2026.
Closure is linked to the un-audited financial results for the quarter ending June 30, 2026.
Restriction covers Directors, Promoters, Designated Persons, and their immediate relatives.
Trading window will remain closed until 48 hours after the results are declared.

💡 No action is required as this is a routine regulatory filing. Investors should look out for the upcoming Q1 earnings announcement to evaluate the company's performance.

Reliance Chemotex Issues KYC Updation Notice and IEPF Share Transfer Warning by Sept 15, 2026

🟡 NEUTRAL ⭐ 3/10

REGULATORY 📅 15 Jun 2026, 04:27 PM

Reliance Chemotex Industries Limited has issued a mandatory notice to physical shareholders to update their PAN, KYC, and bank details to remain eligible for dividends and service requests. The company also warned that shares with dividends unclaimed for seven consecutive years will be transferred to the Investor Education and Protection Fund (IEPF) Authority. Shareholders must claim their unpaid dividends by September 15, 2026, to prevent this transfer. Furthermore, the company emphasized that all security transfers will now only be processed in dematerialized form.

Mandatory KYC updation (PAN, Mobile, Bank details) required for all physical shareholders.
Shares with dividends unclaimed for 7 consecutive years are liable for transfer to the IEPF.
Deadline for shareholders to claim unpaid dividends and avoid share transfer is September 15, 2026.
Dividend payments are now restricted to electronic mode only, effective from April 1, 2024.
Security transfers will be processed by the RTA exclusively in dematerialized form.

💡 Physical shareholders should immediately update their KYC details with Bigshare Services and initiate the dematerialization of their shares. Investors with unclaimed dividends must contact the RTA before the September 15 deadline to prevent their shares from being transferred to the IEPF.

Reliance Chemotex Amends Code for Fair Disclosure of UPSI

🟡 NEUTRAL ⭐ 3/10

REGULATORY 📅 30 May 2026, 12:07 PM

Reliance Chemotex Industries Limited has updated its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI) effective May 29, 2026. This amendment follows Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, to ensure uniform and universal dissemination of price-sensitive information. The code defines 'Legitimate Purposes' for sharing information with external stakeholders and mandates the use of a Structured Digital Database for tracking. This move strengthens the company's internal governance framework regarding information transparency and insider trading prevention.

Board of Directors approved the amended UPSI Fair Disclosure Code in a meeting held on May 29, 2026
Company Secretary & Compliance Officer designated as the Chief Investor Relations Officer for UPSI dissemination
Mandates a Structured Digital Database with time-stamping to track UPSI shared with external entities like auditors and lenders
Defines 'Legitimate Purpose' for information sharing to include ordinary course of business with partners and consultants
Ensures all UPSI is handled on a 'need to know' basis to prevent selective disclosure and market misuse

💡 This is a routine regulatory update regarding corporate governance and insider trading policies. No immediate action is required as it does not impact the company's financial fundamentals.

Reliance Chemotex Re-appoints Internal and Cost Auditors for FY 2026-27

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 29 May 2026, 12:41 PM

Reliance Chemotex Industries Limited has announced the re-appointment of its Internal and Cost Auditors for the financial year 2026-27. The Board of Directors, in a meeting held on May 29, 2026, approved M/s. Rajeev Amitabh & Co. as Internal Auditor and M/s. N N & Associates as Cost Auditor. These re-appointments signify continuity in the company's internal control and cost auditing processes. The decision is in compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015.

Re-appointment of M/s. Rajeev Amitabh & Co. as Internal Auditor for FY 2026-27
Re-appointment of M/s. N N & Associates as Cost Auditor for FY 2026-27
Board approval granted during the meeting held on May 29, 2026
Internal Auditor firm M/s. Rajeev Amitabh & Co. has been established since 1990
Cost Auditor firm M/s. N N & Associates has extensive experience across multiple industrial sectors

💡 This is a routine governance matter ensuring continuity in financial oversight; no immediate action is required from investors.

Reliance Chemotex FY26 Net Profit Rises 30% to ₹5.26 Cr; Recommends 5% Dividend

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 29 May 2026, 12:26 PM

Reliance Chemotex reported a strong 30% year-on-year growth in annual net profit, reaching ₹526.15 lacs for FY26 compared to ₹404.52 lacs in FY25. While annual revenue from operations remained relatively flat at ₹36,200.58 lacs, the company managed to improve its bottom line significantly. For the fourth quarter (Q4 FY26), revenue grew 7.2% YoY to ₹8,817.66 lacs, although net profit saw a slight dip to ₹174.59 lacs from ₹184.02 lacs in the same period last year. The Board has also recommended a final dividend of ₹0.50 per share.

Annual Net Profit increased by 30.07% YoY to ₹526.15 lacs in FY26.
Revenue from operations for the full year FY26 stood at ₹36,200.58 lacs.
Q4 FY26 revenue grew by 7.2% YoY to ₹8,817.66 lacs compared to Q4 FY25.
Board recommended a final dividend of 5% (₹0.50 per equity share of ₹10 face value).
Annual Basic and Diluted EPS improved to ₹6.97 from ₹5.36 in the previous year.

💡 Investors may view the annual profit growth and dividend recommendation positively, though they should monitor the slight margin compression observed in the Q4 results.

View All RELCHEMQ Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Revenue from operations grew 4.19% YoY to INR 191.89 Cr in H1 FY26 from INR 184.17 Cr in H1 FY25. Segment-specific growth is not detailed, but the company focuses on synthetic blended yarns and technical textiles.

Geographic Revenue Split

Not disclosed in available documents, though the company notes a focus on both export sales and revitalizing sales in the domestic Indian market.

Profitability Margins

Operating profit margin stood at 7.74% in FY24, up from 6.78% in FY23. Net profit margin improved to 1.13% in FY24 from 0.86% in FY23, primarily aided by deferred tax adjustments despite geopolitical pressures.

EBITDA Margin

OPBDITA/OI margin was 9.5% in FY24, a decline from 10.9% in FY23. This contraction reflects higher operating costs and adverse market situations despite a slight revenue increase.

Capital Expenditure

The company completed expansion projects totaling approximately INR 130 Cr, which added 13,440 spindles to its capacity. Capital Work in Progress stood at INR 0.81 Cr as of September 30, 2025.

Credit Rating & Borrowing

The company was rated [CRISIL]B(Stable)/[CRISIL]A4; ISSUER NOT COOPERATING as of September 30, 2024. Interest coverage ratio declined significantly from 2.90x in FY23 to 1.81x in FY24 due to higher interest rates and lower profitability.

⚙️ Operational Drivers

Raw Materials

Key raw materials include Polyester, Viscose, and Acrylic fiber. Raw material consumption of INR 94.93 Cr represented 49.4% of total revenue in H1 FY26.

Import Sources

Primarily sourced from the domestic Indian market to support manufacturing units in Udaipur, Rajasthan.

Key Suppliers

Key suppliers include Reliance Industries Limited for polyester staple fiber and Grasim Industries Limited for viscose staple fiber.

Capacity Expansion

Current capacity was expanded by 13,440 spindles, representing a ~25% increase in total capacity. The expansion also included modernizing and expanding dyeing facilities.

Raw Material Costs

Raw material costs were INR 94.93 Cr in H1 FY26, a slight decrease of 2.4% from INR 97.27 Cr in H1 FY25, suggesting improved procurement or mix despite revenue growth.

Manufacturing Efficiency

Focus on 'value-added' product offerings and strategic cost-reduction efforts spearheaded by executive leadership.

Logistics & Distribution

Not disclosed as a specific percentage, but the company manages exports and domestic distribution from its Rajasthan unit.

📈 Strategic Growth

Expected Growth Rate

25%

Growth Strategy

Growth is driven by a 25% capacity expansion (13,440 spindles) and diversification into technical, industrial, and medical textiles. The company is also focusing on R&D to expand value-added product offerings and revitalizing domestic sales while maintaining export momentum.

Products & Services

Synthetic blended yarns, technical textiles, industrial textiles, medical textiles, and dyed yarns.

Brand Portfolio

Reliance Chemotex Industries Limited (RCIL).

New Products/Services

Diversification into technical and medical textiles is expected to contribute to higher-margin revenue streams, though specific % contribution is not disclosed.

Market Expansion

Focus on expanding the value-added product portfolio in both domestic and international export markets.

🌍 External Factors

Industry Trends

The textile industry is facing challenges from high interest rates and fluctuating raw material costs. The trend is shifting toward technical and medical textiles where RCIL is positioning itself for future growth.

Competitive Landscape

Competes in the fragmented synthetic yarn and textile market; key competitors are not named but include other large-scale spinning mills.

Competitive Moat

Moat is built on specialized manufacturing processes (Toyota Production System) and a niche focus on technical/industrial textiles, which are more durable than standard apparel yarns.

Macro Economic Sensitivity

Highly sensitive to global demand and the Indian economy's GDP growth (6.5% in FY25). Geopolitical situations are cited as a reason for recent profit pressure.

Consumer Behavior

Shift toward technical and medical textiles is driving the company's product diversification strategy.

Geopolitical Risks

Uncertainties such as US investment policies and global supply chain disruptions impact export demand and raw material pricing.

⚖️ Regulatory & Governance

Industry Regulations

Operations are subject to government import/export policies and textile industry regulations; the company monitors these as part of its regulatory risk management.

Taxation Policy Impact

The company benefited from deferred tax credits, which increased the net profit margin despite lower operating profits. Current tax for H1 FY26 was INR 0.38 Cr.

Legal Contingencies

The Audit Committee reviews 'substantial defaults' in payments to creditors/depositors, though no specific pending court case values were disclosed.

⚠️ Risk Analysis

Key Uncertainties

Fluctuations in petroleum prices (raw material link), interest rate volatility (impacting debt servicing), and geopolitical shifts affecting export markets.